NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 41 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,634 | +23.8% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $21,512 | -17.3% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | -64.9% | 102,440 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $74,000 | -8.6% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $81,000 | -20.6% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $102,000 | -43.0% | 102,440 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $179,000 | -4.3% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $187,000 | -54.3% | 102,440 | -49.4% | 0.00% | -62.5% |
| Q1 2021 | $409,000 | +73.3% | 202,440 | +84.1% | 0.01% | +60.0% |
| Q4 2020 | $236,000 | -34.1% | 109,940 | -17.1% | 0.01% | -37.5% |
| Q3 2020 | $358,000 | +45.5% | 132,540 | +111.9% | 0.01% | +60.0% |
| Q2 2020 | $246,000 | – | 62,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 466,688 | $41,862 | 0.02% |
| Warberg Asset Management LLC | 194,997 | $17,491 | 0.00% |
| Virtu Financial LLC | 333,069 | $30 | 0.00% |
| UBS Group AG | 149,612 | $13,466 | 0.00% |
| NewEdge Advisors, LLC | 412 | $36 | 0.00% |
| Parallel Advisors, LLC | 350 | $31 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,604 | $143 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,632 | $504 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $3,535 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |